I'm not sure that the Macular partnership in and of itself is going to be huge for Fuse, but if Macular's formula slows the progression of Macular Degeneration by 17% and if Fuse's oral drop technology increases the speed and efficacy of Macular's formula, then it can't be anything but good for Fuse. Some will view it as a proof of concept and realize that there are a multitude of other products that could be improved by such a delivery formula.